Effect of Belimumab on the Cutaneous Manifestations of Patients With Lupus Erythematosus
This retrospective analysis demonstrated that belimumab has long-term benefits for cutaneous manifestations of patients with lupus erythematosus. However, prospective studies in larger patient populations are needed to confirm the findings.
Authors
- Sarah Rösing (ORCID: https://orcid.org/0000-0002-3772-3590)
- M. Aringer
- Claudia Günther (ORCID: https://orcid.org/0000-0002-4330-1861)
- Nicolai Leuchten
- Nick Zimmermann (ORCID: https://orcid.org/0000-0003-2277-8000)
- Diana Schellin
Institutions
- University Children's Hospital Tübingen (DE)
- Helios Klinikum Erfurt (DE)
- University Hospital Carl Gustav Carus (DE)
- University of Tübingen (DE)
Publication Details
- Journal
- International Journal of Dermatology
- Published
- 2026-01-22
- DOI
- https://doi.org/10.1111/ijd.70251
- Primary Topic
- Systemic Lupus Erythematosus Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00